Hexicon AB (OSTO:HEXI, Financial) is set to release its Q3 2024 earnings on Nov 29, 2024. The consensus estimate for Q3 2024 revenue is $0.00 billion, and the earnings are expected to come in at -$0.13 per share. The full year 2024's revenue is expected to be $0.18 billion, and the earnings are expected to be -$0.04 per share. More detailed estimate data can be found on the Forecast page.
Hexicon AB (OSTO:HEXI, Financial) Estimates Trends
Revenue estimates for Hexicon AB (OSTO:HEXI) have remained flat at $0.18 billion for the full year 2024 and flat at $0.51 billion for 2025 over the past 90 days. Earnings estimates for Hexicon AB (OSTO:HEXI) have remained flat at -$0.04 per share for the full year 2024 and flat at $0.72 per share for 2025 over the past 90 days.
Hexicon AB (OSTO:HEXI, Financial) Reported History
In the previous quarter of 2024-06-30, Hexicon AB's (OSTO:HEXI) actual revenue was $0.00 billion, which beat analysts' revenue expectations of $0.00 billion by 10.00%. Hexicon AB's (OSTO:HEXI) actual earnings were -$0.13 per share, which missed analysts' earnings expectations of -$0.12 per share by -8.33%. After releasing the results, Hexicon AB (OSTO:HEXI) was down by -10.61% in one day.
Hexicon AB (OSTO:HEXI, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 2 analysts, the average target price for Hexicon AB (OSTO:HEXI) is $1.07 with a high estimate of $1.90 and a low estimate of $0.23. The average target implies an upside of 489.70% from the current price of $0.18.
Based on GuruFocus estimates, the estimated GF Value for Hexicon AB (OSTO:HEXI, Financial) in one year is $0.28, suggesting an upside of 55.04% from the current price of $0.18.
Based on the consensus recommendation from 2 brokerage firms, Hexicon AB's (OSTO:HEXI, Financial) average brokerage recommendation is currently 3.0, indicating a "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
